Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Authors / Jasmine

Jasmine

Jasmine is a Principal Scientist, Quality by Design, at Dr. Reddy’s Laboratories SA

  • Contributions

Time to Dive into Design of Experiments

December 14, 2016

Data, data everywhere... But pharma is not making the most out of it. Multivariate statistical modeling can play a key role in Quality by Design. Here’s how.

1 min read

Time to Dive into Design of Experiments

Building a QbD Masterpiece with Six Sigma

August 17, 2016

Are you stuck at a Five Sigma improvement project? Or is Quality-by-Design based product development too cumbersome? Many people struggle with QbD, but there are secrets to success.

1 min read

Building a QbD Masterpiece with Six Sigma

The Beginning of the End of Quality by Design

May 16, 2016

Where did Quality by Design come from? Where will it lead to in pharma? And is there a day when the concept will no longer exist?

1 min read

The Beginning of the End of Quality by Design

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.